Omni Bio Pharmaceutical (Omni Bio Pharmaceutical) EV-to-EBIT : -0.73 (As of May. 06, 2024)

Omni Bio Pharmaceutical EV-to-EBIT Chart

Omni Bio Pharmaceutical Annual Data
	Trend	Dec06	Dec07	Dec08	Mar09	Mar10	Mar11	Mar12	Mar13	Mar14
EV-to-EBIT		Get a 7-Day Free Trial				-21.87	-10.53	-10.01	-1.60	-4.79

Omni Bio Pharmaceutical Quarterly Data
	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14
EV-to-EBIT	Get a 7-Day Free Trial															-3.22	-4.79	-3.25	-3.32	-4.82

Competitive Comparison of Omni Bio Pharmaceutical's EV-to-EBIT

For the Biotechnology subindustry, Omni Bio Pharmaceutical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Omni Bio Pharmaceutical's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Omni Bio Pharmaceutical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Omni Bio Pharmaceutical's EV-to-EBIT falls into.

Omni Bio Pharmaceutical EV-to-EBIT Calculation

Omni Bio Pharmaceutical's EV-to-EBIT for today is calculated as:

Omni Bio Pharmaceutical's current Enterprise Value is $2.49 Mil.
Omni Bio Pharmaceutical's EBIT for the trailing twelve months (TTM) ended in Dec. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.42 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omni Bio Pharmaceutical  (GREY:OMBP) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Omni Bio Pharmaceutical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2014 is calculated as:

Omni Bio Pharmaceutical's Enterprise Value for the quarter that ended in Dec. 2014 was $16.81 Mil.
Omni Bio Pharmaceutical's EBIT for the trailing twelve months (TTM) ended in Dec. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.42 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omni Bio Pharmaceutical EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Omni Bio Pharmaceutical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Omni Bio Pharmaceutical (Omni Bio Pharmaceutical) Business Description